Posts in category: News

On the evening of December 22, 2025, the city of Kirkuk hosted a distinguished scientific gathering dedicated to advances in otolaryngology and respiratory care. The event, organized by Erbozeta in collaboration with XenoFarma, took place at the renowned Said Kareem Restaurant and brought together leading ENT specialists from the region.

The scientific session focused on “A Novel Mucoadhesive Approach to Upper Respiratory Tract Inflammation and Symptoms,” providing an in-depth exploration of innovative therapeutic strategies designed to enhance local efficacy and symptom control in upper respiratory tract conditions.

The discussion highlighted the clinical challenges associated with upper respiratory tract inflammation, including symptom persistence, patient adherence, and the need for targeted local therapies. Emphasis was placed on the advantages of mucoadhesive formulations, particularly their ability to prolong mucosal contact time, improve therapeutic effectiveness, and support patient comfort.

The event fostered a dynamic and interactive scientific environment, encouraging open discussion and experience sharing among ENT specialists regarding modern respiratory treatment approaches and evolving clinical practices.

Through such focused educational initiatives, XenoFarma continues to support scientific excellence, innovation, and continuous medical education, reinforcing its commitment to advancing respiratory and ENT care across Iraq.

Event Date: December 22, 2025
Start Time: 8:00 PM
Venue: Said Kareem Restaurant
City: Kirkuk, Iraq

An educational scientific session titled “Contemporary UTI Management in Line with Updated EAU Guidelines” was successfully held on December 21, 2025, at HuQQabaz, Empire World – Erbil.

The session focused on modern strategies for the management of urinary tract infections (UTIs) in accordance with the latest updates from the European Association of Urology (EAU) guidelines. Key topics included contemporary definitions of UTIs, guideline-based diagnostic approaches, rational antibiotic selection, and optimal treatment duration.

Special emphasis was placed on antibiotic stewardship in the context of rising antimicrobial resistance, highlighting the importance of evidence-based prescribing practices to reduce resistance development while maintaining clinical efficacy. The discussion also addressed emerging challenges in recurrent and complicated UTIs and the need for guideline-driven decision-making in daily clinical practice.

The session provided an interactive educational platform for healthcare professionals to exchange knowledge and align clinical practice with the most recent European recommendations.

Through such scientific activities, XenoFarma continues to support continuous medical education and the dissemination of up-to-date, evidence-based guidelines to improve patient care and clinical outcomes across Iraq.

Event Date: December 21, 2025
Start Time: 8:00 PM
Venue: HuQQabaz – Empire World
Location: Erbil, Iraq

XenoFarma successfully participated in a scientific symposium titled “Highlights of the Pharmaceutical and Nutraceutical Industries: The Impact of Elea and Erbozeta,” held on January 22, 2025, in Ranya.

The symposium featured a comprehensive scientific lecture that provided an in-depth overview of recent developments within the pharmaceutical and nutraceutical industries, with particular focus on the contributions and impact of Elea and Erbozeta. The session addressed evolving therapeutic trends, innovation pathways, and the growing role of nutraceuticals in modern healthcare.

XenoFarma was officially represented by Dr. Sofian M. Sulaiman, Marketing Manager, and Dr. Hoshang, Sales Manager, who delivered a focused scientific and industry-oriented presentation. Their session highlighted key aspects of pharmaceutical and nutraceutical innovation, emphasizing the integration of evidence-based products into daily clinical practice and the importance of aligning industry development with patient-centered care.

The symposium provided an interactive platform for discussion and knowledge exchange, strengthening professional awareness of emerging industry trends and reinforcing collaboration between healthcare professionals and the pharmaceutical sector.

XenoFarma continues to support scientific education and professional engagement through high-quality events that promote innovation, clinical confidence, and sustainable healthcare development across Iraq.

Event Date: January 22, 2025
Start Time: 11:30 PM
Location: Ranya, Iraq

XenoFarma participated in an educational scientific session focused on contemporary management strategies for urinary tract infections (UTIs), held on December 17, 2025, at the Titanic Hotel in Sulaymaniyah. The session was conducted in alignment with the updated Infectious Diseases Society of America (IDSA) guidelines, addressing the evolving challenges of antimicrobial resistance in UTI management.

The discussion covered guideline-recommended diagnostic pathways, appropriate antibiotic selection and treatment duration, and the principles of antimicrobial stewardship aimed at minimizing resistance development. Special emphasis was placed on the growing clinical relevance of antibiotic-associated dysbiosis and its role in recurrent and complicated UTIs.

In line with current international recommendations that emphasize non-antibiotic preventive and adjunctive strategies, the session explored evidence-based supportive approaches designed to reduce recurrence while preserving the urinary microbiome. Within this framework, UROVITA® from SIIT, an innovative Italian company, was presented as a microbiota-friendly adjunct that complements modern, guideline-driven UTI management.

The session promoted scientific dialogue and practical insight into integrated UTI care, reinforcing the importance of balancing effective infection control with long-term microbiome preservation.

XenoFarma remains committed to supporting continuous medical education and advancing evidence-based practices that address modern clinical challenges in infectious diseases.

Event Date: December 17, 2025
Start Time: 7:30 PM
Venue: Titanic Hotel – Sulaymaniyah
Address: Malik Mahmmod Circle, Goizha Area, Near Chavy Land, Sulaymaniyah, Iraq

XenoFarma successfully participated in a scientific symposium titled “Modern Treatment of Allergic and Non-Allergic Rhinitis: Phytotherapy and Hypertonic Solutions,” held on December 15, 2025, at the White Tower Hotel in Mosul.

The symposium featured a comprehensive scientific lecture that provided an up-to-date overview of contemporary therapeutic strategies for the management of allergic and non-allergic rhinitis. The session addressed current clinical challenges and emphasized the importance of evidence-based, patient-centered treatment approaches.

XenoFarma was officially represented by Dr. Sofian M. Sulaiman, Marketing Manager, who delivered a focused scientific presentation highlighting an innovative approach to rhinitis management through the use of Allerdep® and Influprop® nasal sprays. The presentation detailed the pharmacological properties, mechanisms of action, and clinical applications of both products in alleviating nasal inflammation and improving patient quality of life.

In addition to clinical efficacy, the discussion addressed pricing and cost-effectiveness, including a comparative overview of Erbozeta products’ pricing inside Iraq versus international markets, emphasizing accessibility and value for patients and healthcare providers.

Overall, the symposium represented a valuable scientific and promotional initiative for XenoFarma, enhancing product visibility, strengthening clinical confidence, and fostering productive professional relationships with healthcare specialists in the region.

Event Date: December 15, 2025
Start Time: 8:30 PM
Venue: White Tower Hotel
City: Mosul, Iraq

The scientific symposium titled “Weight Regain After Bariatric Surgery” was successfully held in Sulaimaniyah on December 11, 2025, with XenoFarma participating as a sponsoring company. The event brought together approximately 30 general surgeons, reflecting strong professional interest and active scientific engagement in post-bariatric care.

The symposium featured a comprehensive scientific lecture delivered by Dr. Aram, General Surgeon (Sulaimaniyah), who addressed the key clinical factors contributing to weight regain following bariatric surgery. The session highlighted common postoperative challenges, patient-related factors, and the importance of long-term gastrointestinal and metabolic management.

XenoFarma was officially represented by Dr. Sofian M. Sulaiman, Marketing Manager, and Dr. Hoshang, Sales Manager, who delivered a focused scientific presentation on the role of butyrate in intestinal health. The presentation reviewed the pharmacological mechanisms and clinical applications of ProIBS® Dual Blister Capsules and Butirect® Sustained-Release Suppositories, emphasizing their role in the management of irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD).

The discussion addressed gastrointestinal health throughout the entire digestive tract, from the duodenum to the rectum, with particular emphasis on postoperative bowel function and mucosal integrity. The symposium concluded with a highly interactive discussion, enriched by clinical insights from Dr. Mozhda, General Surgeon, who shared real-world experience with Xenofarma’s products.

A notable highlight of the event was Dr. Aram’s strong clinical endorsement of Butirect®, based on his personal experience in the routine management of anal fissures, which generated significant interest and confidence among attending surgeons.

Overall, the symposium represented a valuable scientific and promotional activity for XenoFarma, enhancing product visibility, reinforcing clinical trust, and strengthening professional relationships with surgeons in the region.

Event Date: December 11, 2025
Start Time: 12:30 PM
Venue: Titanic Hotel – Sulaimaniyah
City: Sulaimaniyah, Iraq

Event Date: December 15, 2025
Start Time: 12:30 PM
Venue: Rotana by Arjaan – Erbil
Address: 100 Meter Road, Erbil, Iraq

XenoFarma successfully organized a high-level scientific symposium titled “Scientific Symposium: Advancing Pediatric and Orthopedic Care” on Monday, December 15, 2025, at the prestigious Rotana by Arjaan in Erbil.

The event brought together a distinguished group of Pediatric Surgeons and Orthopedic Surgeons, creating a collaborative platform for advanced scientific discussion and knowledge exchange. The symposium addressed critical topics related to pediatric surgery, orthopedic oncology, and the foundational role of nutrition in pediatric growth and development.

Scientific Sessions

1. Bone Tumors in Pediatrics
Presented by Dr. Sarkawt Sarteep, Senior Orthopedic Surgeon
This session provided in-depth insights into the diagnosis, management, and latest treatment strategies for pediatric bone tumors, emphasizing the importance of specialized and multidisciplinary approaches to ensure optimal patient outcomes.

2. Complete Primary Repair of Exstrophy
Presented by Dr. Abdulrahman Omar, Pediatric Surgeon
Dr. Omar shared his clinical expertise on the complex procedure of complete primary repair of exstrophy, highlighting surgical techniques aimed at achieving optimal functional and cosmetic results while minimizing long-term complications.

3. Next-Generation Oral Nutraceuticals for Optimizing Pediatric Growth and Development
Presented by Dr. Rawand, MSc in Pharmaceutical Technology, Product & Business Development Manager – XenoFarma
The final session explored the scientific foundation behind next-generation oral nutraceuticals, focusing on evidence-based nutritional strategies that support pediatric growth, neurodevelopment, and long-term overall health.

The symposium fostered meaningful scientific dialogue and practical knowledge exchange, reinforcing the importance of integrated medical, surgical, and nutritional approaches in pediatric healthcare.

XenoFarma, in collaboration with Erbozeta – Energia Verde (Italy), successfully organized a Round Table Discussion (RTD) with a group of leading urologists in Baghdad on Thursday, December 5, 2025.

The scientific session focused on “Erbozeta’s Approach in the Management of Nephrolithiasis”, with special emphasis on URO3 Plus as a supportive option in the prevention and management of urinary stone disease. During the presentation, current clinical challenges in nephrolithiasis were discussed, including recurrence prevention, patient compliance, and long-term metabolic management.

The discussion highlighted the mechanism of action, clinical benefits, and real-world use of URO3 Plus, supported by scientific evidence and practical experience from daily urology practice. Participating physicians actively exchanged insights on patient selection, adjunctive therapy, and integration of nutraceuticals into standard urological care.

The RTD provided an interactive platform for open dialogue, allowing urologists to share case-based experiences and discuss modern strategies aimed at improving patient outcomes while reducing stone recurrence.

XenoFarma remains committed to supporting continuous medical education and fostering scientific exchange through focused, high-quality meetings with healthcare professionals across Iraq.

Event Details

• Event Type: Round Table Discussion (RTD)
• Specialty: Urology
• Topic: Management of Nephrolithiasis – Erbozeta Touch
• Product Highlight: URO3 Plus
• Date: December 5, 2025
• Location: Baghdad, Iraq

XenoFarma, in collaboration with Erbozeta – Energia Verde, successfully organized a scientific educational session for otolaryngologists in Mosul on Monday, December 1, 2025, at the White Tower Hotel.

The session focused on “The Latest Clinical Insights and Management Approaches in Upper Respiratory Tract Disorders.” The meeting addressed current clinical challenges in ENT practice, highlighting evidence-based strategies and practical approaches applicable to daily patient care.

The discussion provided valuable updates on modern diagnostic and therapeutic perspectives, aiming to support otolaryngologists in optimizing treatment outcomes for upper respiratory tract conditions.

XenoFarma remains committed to continuous medical education and to supporting healthcare professionals through high-quality scientific activities across Iraq.

Monday 1-12-2025